TipRanks

BASH ALAN Insider Profile

4 Followers
BASH ALAN, Interim CEO at Legend Biotech, holds 35.14K shares in Legend Biotech (Ticker: LEGN), holds ― shares in Checkmate Pharmaceuticals (Ticker: CMPI).
tipranks
BASH ALAN

BASH ALAN
Legend Biotech (LEGN)
Interim CEO

Not Ranked
BASH ALAN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$679K
100.00%
A breakdown of BASH ALAN's holdings

Insider Roles

Legend Biotech
(LEGN)
Interim CEO
Roles that BASH ALAN holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by BASH ALAN

BASH ALAN's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Legend Biotech
Aug 18, 2026
Interim CEO
Uninformative Buy
―
$678.94K
CMPI
Checkmate Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see BASH ALAN's performance on stock

BASH ALAN insider profile FAQ

What is the percentage of profitable transactions made by BASH ALAN?
The percentage of profitable transactions made by BASH ALAN is ―.
    What is the average return per transaction made by BASH ALAN?
    The average return per transaction made by BASH ALAN is ―.
      What stocks does BASH ALAN hold?
      BASH ALAN holds: LEGN, CMPI stocks.
        What was BASH ALAN’s latest transaction?
        BASH ALAN latest transaction was an Uninformative Buy of ―.
          What was BASH ALAN's most profitable transaction?
          BASH ALAN’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is BASH ALAN's role in Legend Biotech?
            BASH ALAN's role in Legend Biotech is Interim CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.